Developer docs
API playgroundTry for free, no card

Search company profiles

Caelo

Full company profile

uuid000vuq5

Namestring
Caelo
Legal namestring
Caesar & Loretz GmbH
Websiteurl
caelo.de
Company typeenum
Private
Founded yearint
1893
Descriptiontext

Caelo (legal name Caesar & Loretz GmbH) is a German pharmaceutical raw materials and compounding products company founded in 1893 and headquartered in Hilden, with a secondary production site in Bonn. The company supplies high-quality APIs (active pharmaceutical ingredients), excipients, semi-solid bases, medicinal herbs, essential oils, and packaging materials that meet GMP, Ph.Eur., and DAC/NRF pharmacopoeial standards, manufactured in two Class D clean rooms with on-site purified water production. Caelo also markets a portfolio of more than 130 finished OTC and standard-authorization (Standardzulassung) products, including Dronabinol concentrates, hydrogen peroxide solution, and the Aluminiumchlorid roll-on, alongside toll manufacturing (Lohnherstellung) services for the pharmaceutical, food, and cosmetics industries.

The company's primary customers are German community and hospital pharmacies that use Caelo materials for individual prescription compounding (Rezeptur) and batch production (Defektur), with secondary industrial and end-consumer channels. Distribution runs through pharmaceutical wholesale and direct sales, with professional pricing and detailed product information gated behind a DocCheck-authenticated B2B portal. Caelo monetizes through one-time product sales and contract manufacturing; education (Caelo Campus webinars, the Rezeptursymposium, Rezepturtage) and the Rezepturforum community platform are free, serving as loyalty/retention layers and demand-generation levers.

Caelo differentiates itself through 130+ years of regulatory expertise, integrated batch-specific analysis certificate retrieval via the Dr. Lennartz laboratory software (with 2D code product tracking), the Rezeptur-Hotline, and continuing education programs that are accredited for pharmacy professional development points. The company is privately held by the von der Linde family, with Asiye Dogan appointed Managing Director in September 2023 alongside managing partner Ulrich von der Linde. It has no external PE/VC backing, no public listing, and no M&A or funding activity disclosed in the available data.

Short descriptiontext

Caelo (Caesar & Loretz GmbH) is a 130+ year-old German pharmaceutical raw materials and compounding products manufacturer that supplies APIs, excipients, semi-solid bases, and finished OTC products to community and hospital pharmacies, plus industrial customers, primarily in Germany.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersHilden, Germany
HQ citystring
Hilden
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical raw materials, compounding substances, semi-solid bases, essential oils, pharmacy products
Industry2 codes
1Compounding Ingredient & API Distributors (Pharma Supply)
CodeHLAIAJAOPrimaryYes
2Preservatives & Antimicrobials (Sorbates, Benzoates, Natamycin, Cultured Dextrose)
CodeCRADAOAFPrimaryNo
NAICS code3 codes
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical Preparation Manufacturing325412
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers423450
SIC code3 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Raw Materials
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Pharmaceutical Raw Materials (API, Rezeptursubstanzen)
TypeOne Time License
Description

Sale of pharmaceutical starting materials including active pharmaceutical ingredients (APIs), excipients, base formulations, and essential oils to pharmacies for prescription compounding.

caelo.de
2Finished Products (HV-Produkte, Standardzulassungen)
TypeOne Time License
Description

Sale of ready-to-use products including standard formulations, OTC products, herbal teas, essential oils, honey, and cosmetic products under Caelo brand.

caelo.de
3Toll Manufacturing (Lohnherstellung)
TypeProfessional Services
Description

Contract manufacturing services for pharmaceutical, food, and cosmetics industry customers.

caelo.de
4Training and Education (Caelo Campus)
TypeFreemium
Description

Free webinars and in-person seminars providing continuing education for pharmacy staff, accredited for professional development points.

caelo.de
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Professional/B2B pricing (restricted access)
ModelOtherBilling cadenceMonthly
Notes

Direct pricing available only to authenticated pharmacy professionals via DocCheck login system.

caelo.de
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1ProFuma
Description

Essential oils product line for aromatherapy and DIY cosmetics, featuring natural fragrances for personal care products.

caelo.de
+1 more record
Core offering1 text field

Caelo (Caesar & Loretz GmbH) manufactures and distributes high-quality pharmaceutical raw materials and finished compounding products for German community and hospital pharmacies, the pharmaceutical/food/cosmetics industries, and selected end consumers. Its portfolio spans active pharmaceutical ingredients (APIs), compounding substances, semi-solid bases, medicinal herbs, essential oils, OTC products, and finished medicinal products such as Dronabinol concentrate, complemented by toll manufacturing and pharmacist training services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 167 tonnes CO2 savings per year through photovoltaic installation
+1 more record
Product overview1 text field

Caelo (Caesar & Loretz GmbH) is a German pharmaceutical raw materials company serving approximately 130 years, acting as a partner to community and hospital pharmacies, the pharmaceutical, food, and cosmetics industries, and end consumers. Its product portfolio is organized into two main categories: (1) Rezeptur-Produkte (compounding products) — encompassing pharmaceutical APIs (active pharmaceutical ingredients), compounding substances, semi-solid bases (Halbfeste Grundlagen), medicinal herbs and animal products, essential oils (including the Profuma sub-brand), and packaging materials; and (2) HV-Produkte (OTC/pharmacy-sale products) — including teas, essential oils, spices, honey, herbal medicines, cosmetics, and finished medicinal products such as Dronabinol concentrates, hydrogen peroxide solution 3%, the aluminium chloride hexahydrate roll-on, and suspension bases. Caelo differentiates itself through integrated services including a Caelo Campus continuing education platform (free accredited webinars and seminars), the annual Rezeptursymposium, in-person Rezepturtage training events, a compounding hotline, the Rezepturforum community platform, and a Dr. Lennartz Laborprogramm integration for certificate access. The company operates new cleanroom production facilities and a GDP-compliant warehouse in Hilden, Germany, and maintains a second production site in Bonn.

Product and service19 records
1Pharmazeutische Ausgangsstoffe (Pharmaceutical Raw Materials / APIs)
CategoryPharmaceutical raw materials / APIs
Description

High-quality active pharmaceutical ingredients (APIs) and pharmaceutical starting materials for compounding in pharmacies, compliant with DAC, NRF, Ph.Eur., and GMP standards.

2Rezeptursubstanzen (Compounding Substances)
CategoryCompounding substances
Description

Substances for individual prescription preparation (Rezeptur) in pharmacies, including powdered and bulk forms.

3Halbfeste Grundlagen (Semi-Solid Bases)
CategorySemi-solid pharmaceutical bases
Description

Ready-to-use semi-solid bases for topical preparations, including hydrophilic creams, washable ointment bases, and specialized bases such as the Abwaschbare Salbengrundlage (NRF S.31.) and Lotio zinci oxidati SR.

4Heilkräuter & Tierische Produkte (Medicinal Herbs & Animal Products)
CategoryMedicinal herbs and animal-derived pharmaceutical materials
Description

Medicinal herbs, herbal drugs, and animal-derived products for pharmaceutical compounding and teas.

5Profuma Ätherische Öle (Essential Oils)
CategoryEssential oils
Description

Sub-brand of essential oils for aromatherapy and DIY cosmetics, enabling do-it-yourself cosmetic production including body oils, nail oils, and lip care products without microplastics or unwanted ingredients.

6Wasserstoffperoxid-Lösung 3% (Hydrogen Peroxide Solution 3%)
CategoryFinished medicinal product
Description

Hydrogen peroxide solution 3% as a standard-authorization (Standardzulassung) finished medicinal product for wound cleaning, mouth disinfection, and gargling, available in 100ml, 200ml, 500ml, and 1L formats.

7Aluminiumchlorid Hexahydrat 20% Roll-On
CategoryFinished cosmetic product
Description

Ready-to-use cosmetic antiperspirant roll-on containing 20% aluminium chloride hexahydrate in a viscous solution, designed for pharmacy sale without compounding effort.

8Caelo Dronabinol-Konzentrat 125 mg/ml
CategoryFinished medicinal product
Description

High-concentration (125 mg/ml) Dronabinol concentrate enabling simplified pharmacy compounding of oil-based THC drops per NRF 22.8.

9Isopropanol 70% Biozidprodukte (Isopropanol 70% Biocidal Products)
CategoryFinished biocidal product
Description

Two biocidal products containing Isopropanol 70% for hand disinfection.

10Grundlage für Suspensionen zum Einnehmen DAC (Oral Suspension Base DAC)
CategoryFinished medicinal product
Description

Ready-to-use viscous carrier solution for oral suspensions, DAC-compliant, suitable for pediatric patients including infants under 2 years, and patients with swallowing difficulties; free of flavors, fructose, and buffering substances.

11Inertgas Argon (Inert Argon Gas)
CategoryPharmaceutical processing supply
Description

Inert argon gas in a 1L pressure gas cylinder (12 gas liters) with a reusable valve, used for layering sensitive, oxidation-prone, hydrolysis-sensitive, or hygroscopic substances in pharmacies to ensure shelf life until the printed expiry date.

12HV-Produkte (Over-the-Counter / Pharmacy-Sale Products)
CategoryOTC / pharmacy-sale products
Description

Wide range of OTC and pharmacy-sale products including teas, essential oils, spices, honey, herbal medicines, and cosmetics in pharmacy-ready packaging, relieving pharmacies of testing and documentation obligations.

13Lohnherstellung (Toll Manufacturing)
CategoryContract manufacturing services
Description

Contract manufacturing services for pharmaceutical, food, and cosmetics industry customers, leveraging Caelo's cleanroom production, purified water plant, and packaging infrastructure.

14Caelo Campus Fortbildungen (Caelo Campus Continuing Education)
CategoryTraining and education services
Description

Free, accredited continuing education platform for pharmacy staff (pharmacists, PTAs), offering webinars and in-person seminars covering compounding (Rezeptur) topics, analytical methods, and regulatory updates; webinars last 60-90 minutes and award accreditation points.

15Rezeptursymposium
CategoryContinuing education event service
Description

Annual continuing education symposium for pharmacists and pharmacy technicians organized jointly with WEPA Apothekenbedarf, featuring plenary lectures and hands-on workshops; awards 8 accreditation points.

16Rezepturtage
CategoryIn-person training event service
Description

In-person practical training events at Caelo's Hilden facility covering compounding and analytics, with hands-on workshops on topics such as suspensions, plausibility checks, identity testing, and ApBetrO updates.

17Analysenzertifikate (Analysis Certificates) Service
CategoryDocumentation and certificate service
Description

Batch-specific analysis certificates for all Caelo products, accessible via the Dr. Lennartz Laboratory Program with PZN and batch number lookup, and via 2D barcode scanning; certificates are automatically archived in the pharmacy's test protocol.

18Caelo Rezepturhotline (Compounding Hotline)
CategoryTechnical advisory service
Description

Telephone hotline providing pharmacy staff with guidance on concrete questions about individual compounding preparations; available Monday-Friday, 09:00-12:00 and 16:00-18:00.

19Cannabidiol DAC, API
CategoryActive pharmaceutical ingredient
Description

DAC-compliant synthetic Cannabidiol in API quality, added to Caelo's API assortment for pharmacy compounding.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-11-07
Description

Strategic partnership for co-hosting the annual Rezeptursymposium educational event. The 6th edition is scheduled for November 7, 2026 in Leipzig under the motto 'Efficient and safe in compounding daily work'. WEPA and Caelo collaborate on program development, workshops, and participant engagement for pharmacy professionals.

2DAC/NRF (Deutscher Arzneimittelcodex/Nationales Formularium)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Reference standards organization whose formulations and guidelines Caelo follows for product development. DAC/NRF experts serve as speakers at Caelo educational events including Rezeptursymposium and Rezepturtage.

caelo.de
3Dr. Lennartz Laborprogramm
Strategic tierCoreTypeTechnology or Integration
Description

Partnership for integrated certificate management system. Caelo supported development of new certificate server within the Dr. Lennartz laboratory program, enabling automated retrieval and comparison of batch-specific analysis certificates. Caelo is gradually equipping products with 2D codes for scanner integration.

caelo.de
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Training and education provider contributing workshops to the Rezeptursymposium event program.

5AVOXA
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership for cosmetic DIY workshop 'Rezeptur Kosmetik - DIY-Kosmetikprodukte in Apothekenqualität selber herstellen' offered at inspirationLab during trade shows.

caelo.de
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Social enterprise initiative in Eastern Africa (Kenya, Uganda); Caelo supports healthcare access through CSR engagement and quarterly reports shared on website.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

German pharmaceutical company distributing specialty and compounding-relevant products in Germany. Regional peer operating in the same German pharmacy distribution ecosystem as Caelo.

TypeOthers
Description

German pharmaceutical trade media and services provider partnering with Caelo on cosmetic compounding workshops. Ecosystem participant rather than direct competitor, but reflects adjacent professional pharmacy services.

TypeBroad incumbent
Description

Global pharmaceutical excipients and API supplier from BASF, offering much broader portfolio of ingredients across pharma, food, and cosmetics. Overlaps with Caelo's industrial customer base but at significantly larger scale.

TypeDirect peer
Description

Canadian pharmaceutical compounding supplier with global distribution of APIs, excipients, and bases to compounding pharmacies. Comparable in product mix and customer focus, with international reach that contrasts with Caelo's domestic-only footprint.

TypeDirect peer
Description

US-based supplier of APIs, bases, and compounding support services to independent compounding pharmacies. Comparable business model focused on pharmacy compounding with strong educational/training programs analogous to Caelo Campus.

TypeDirect peer
Description

Belgian-based global leader in pharmaceutical compounding supplies, offering APIs, excipients, and semi-solid bases to pharmacies worldwide. Most direct international peer to Caelo with overlapping product portfolio and customer base.

TypeDirect peer
Description

US division of Spectrum Chemical supplying compounding pharmacies with APIs and excipients. Comparable in regulatory-grade raw materials distribution to pharmacy compounders.

TypeDirect peer
Description

US-based compounding supplies company providing APIs, bases, and equipment to compounding pharmacies. Closely analogous product portfolio targeting pharmacy compounders.

TypeBroad incumbent
Description

Major global supplier of pharmaceutical and laboratory chemicals, APIs, and excipients. Competes in adjacent market segments serving industrial pharma customers, but not specialized in pharmacy compounding like Caelo.

TypeDirect peer
Description

US-based distributor of compounding chemicals, equipment, and supplies serving compounding pharmacies. Direct competitor in the raw materials-for-compounding niche.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Caelo

Pharmaceutical Raw Materialscaelo.de

Caelo (Caesar & Loretz GmbH) is a 130+ year-old German pharmaceutical raw materials and compounding products manufacturer that supplies APIs, excipients, semi-solid bases, and finished OTC products to community and hospital pharmacies, plus industrial customers, primarily in Germany.

What Caelo does

Caelo (legal name Caesar & Loretz GmbH) is a German pharmaceutical raw materials and compounding products company founded in 1893 and headquartered in Hilden, with a secondary production site in Bonn. The company supplies high-quality APIs (active pharmaceutical ingredients), excipients, semi-solid bases, medicinal herbs, essential oils, and packaging materials that meet GMP, Ph.Eur., and DAC/NRF pharmacopoeial standards, manufactured in two Class D clean rooms with on-site purified water production. Caelo also markets a portfolio of more than 130 finished OTC and standard-authorization (Standardzulassung) products, including Dronabinol concentrates, hydrogen peroxide solution, and the Aluminiumchlorid roll-on, alongside toll manufacturing (Lohnherstellung) services for the pharmaceutical, food, and cosmetics industries.

The company's primary customers are German community and hospital pharmacies that use Caelo materials for individual prescription compounding (Rezeptur) and batch production (Defektur), with secondary industrial and end-consumer channels. Distribution runs through pharmaceutical wholesale and direct sales, with professional pricing and detailed product information gated behind a DocCheck-authenticated B2B portal. Caelo monetizes through one-time product sales and contract manufacturing; education (Caelo Campus webinars, the Rezeptursymposium, Rezepturtage) and the Rezepturforum community platform are free, serving as loyalty/retention layers and demand-generation levers.

Caelo differentiates itself through 130+ years of regulatory expertise, integrated batch-specific analysis certificate retrieval via the Dr. Lennartz laboratory software (with 2D code product tracking), the Rezeptur-Hotline, and continuing education programs that are accredited for pharmacy professional development points. The company is privately held by the von der Linde family, with Asiye Dogan appointed Managing Director in September 2023 alongside managing partner Ulrich von der Linde. It has no external PE/VC backing, no public listing, and no M&A or funding activity disclosed in the available data.

Caelo firmographics

Firmographics
Name
Caelo
Legal name
Caesar & Loretz GmbH
Website
https://caelo.de
Company type
Private
Founded year
1893
Operating status
Operating
Headcount range
251–500 employees
Short description
Caelo (Caesar & Loretz GmbH) is a 130+ year-old German pharmaceutical raw materials and compounding products manufacturer that supplies APIs, excipients, semi-solid bases, and finished OTC products to community and hospital pharmacies, plus industrial customers, primarily in Germany.
Ownership category
akta.pro rank

Caelo industry classification

Industry
Product category
Pharmaceutical Raw Materials
NAICS
Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
akta.pro secondary industry
Preservatives & Antimicrobials (Sorbates, Benzoates, Natamycin, Cultured Dextrose) (CRADAOAF)

Keywords

  • Pharmaceutical raw materials
  • Compounding substances
  • Semi-solid bases
  • Essential oils
  • Pharmacy products

Where Caelo is headquartered

Location

Headquarters

HQ city
Hilden
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Caelo business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

  1. Pharmaceutical Raw Materials (API, Rezeptursubstanzen): Sale of pharmaceutical starting materials including active pharmaceutical ingredients (APIs), excipients, base formulations, and essential oils to pharmacies for prescription compounding.
  2. Finished Products (HV-Produkte, Standardzulassungen): Sale of ready-to-use products including standard formulations, OTC products, herbal teas, essential oils, honey, and cosmetic products under Caelo brand.
  3. Toll Manufacturing (Lohnherstellung): Contract manufacturing services for pharmaceutical, food, and cosmetics industry customers.
  4. Training and Education (Caelo Campus): Free webinars and in-person seminars providing continuing education for pharmacy staff, accredited for professional development points.

Pricing tiers

ModelBillingPrice
OtherMonthlyProfessional/B2B pricing (restricted access)

Go-to-market motion3 records

Distribution channels3 records

Marketing channels9 records

Caelo product offering

Product offering

Core offering

Caelo (Caesar & Loretz GmbH) manufactures and distributes high-quality pharmaceutical raw materials and finished compounding products for German community and hospital pharmacies, the pharmaceutical/food/cosmetics industries, and selected end consumers. Its portfolio spans active pharmaceutical ingredients (APIs), compounding substances, semi-solid bases, medicinal herbs, essential oils, OTC products, and finished medicinal products such as Dronabinol concentrate, complemented by toll manufacturing and pharmacist training services.

Product overview

Caelo (Caesar & Loretz GmbH) is a German pharmaceutical raw materials company serving approximately 130 years, acting as a partner to community and hospital pharmacies, the pharmaceutical, food, and cosmetics industries, and end consumers. Its product portfolio is organized into two main categories: (1) Rezeptur-Produkte (compounding products) — encompassing pharmaceutical APIs (active pharmaceutical ingredients), compounding substances, semi-solid bases (Halbfeste Grundlagen), medicinal herbs and animal products, essential oils (including the Profuma sub-brand), and packaging materials; and (2) HV-Produkte (OTC/pharmacy-sale products) — including teas, essential oils, spices, honey, herbal medicines, cosmetics, and finished medicinal products such as Dronabinol concentrates, hydrogen peroxide solution 3%, the aluminium chloride hexahydrate roll-on, and suspension bases. Caelo differentiates itself through integrated services including a Caelo Campus continuing education platform (free accredited webinars and seminars), the annual Rezeptursymposium, in-person Rezepturtage training events, a compounding hotline, the Rezepturforum community platform, and a Dr. Lennartz Laborprogramm integration for certificate access. The company operates new cleanroom production facilities and a GDP-compliant warehouse in Hilden, Germany, and maintains a second production site in Bonn.

Differentiator

Problem solved

Functional benefit

Brands

  • ProFuma: Essential oils product line for aromatherapy and DIY cosmetics, featuring natural fragrances for personal care products.
  • Caelo Campus

Products and services

  • Pharmazeutische Ausgangsstoffe (Pharmaceutical Raw Materials / APIs) High-quality active pharmaceutical ingredients (APIs) and pharmaceutical starting materials for compounding in pharmacies, compliant with DAC, NRF, Ph.Eur., and GMP standards.
  • Rezeptursubstanzen (Compounding Substances) Substances for individual prescription preparation (Rezeptur) in pharmacies, including powdered and bulk forms.
  • Halbfeste Grundlagen (Semi-Solid Bases) Ready-to-use semi-solid bases for topical preparations, including hydrophilic creams, washable ointment bases, and specialized bases such as the Abwaschbare Salbengrundlage (NRF S.31.) and Lotio zinci oxidati SR.
  • Heilkräuter & Tierische Produkte (Medicinal Herbs & Animal Products) Medicinal herbs, herbal drugs, and animal-derived products for pharmaceutical compounding and teas.
  • Profuma Ätherische Öle (Essential Oils) Sub-brand of essential oils for aromatherapy and DIY cosmetics, enabling do-it-yourself cosmetic production including body oils, nail oils, and lip care products without microplastics or unwanted ingredients.
  • Wasserstoffperoxid-Lösung 3% (Hydrogen Peroxide Solution 3%) Hydrogen peroxide solution 3% as a standard-authorization (Standardzulassung) finished medicinal product for wound cleaning, mouth disinfection, and gargling, available in 100ml, 200ml, 500ml, and 1L formats.
  • Aluminiumchlorid Hexahydrat 20% Roll-On Ready-to-use cosmetic antiperspirant roll-on containing 20% aluminium chloride hexahydrate in a viscous solution, designed for pharmacy sale without compounding effort.
  • Caelo Dronabinol-Konzentrat 125 mg/ml High-concentration (125 mg/ml) Dronabinol concentrate enabling simplified pharmacy compounding of oil-based THC drops per NRF 22.8.
  • Isopropanol 70% Biozidprodukte (Isopropanol 70% Biocidal Products) Two biocidal products containing Isopropanol 70% for hand disinfection.
  • Grundlage für Suspensionen zum Einnehmen DAC (Oral Suspension Base DAC) Ready-to-use viscous carrier solution for oral suspensions, DAC-compliant, suitable for pediatric patients including infants under 2 years, and patients with swallowing difficulties; free of flavors, fructose, and buffering substances.
  • Inertgas Argon (Inert Argon Gas) Inert argon gas in a 1L pressure gas cylinder (12 gas liters) with a reusable valve, used for layering sensitive, oxidation-prone, hydrolysis-sensitive, or hygroscopic substances in pharmacies to ensure shelf life until the printed expiry date.
  • HV-Produkte (Over-the-Counter / Pharmacy-Sale Products) Wide range of OTC and pharmacy-sale products including teas, essential oils, spices, honey, herbal medicines, and cosmetics in pharmacy-ready packaging, relieving pharmacies of testing and documentation obligations.
  • Lohnherstellung (Toll Manufacturing) Contract manufacturing services for pharmaceutical, food, and cosmetics industry customers, leveraging Caelo's cleanroom production, purified water plant, and packaging infrastructure.
  • Caelo Campus Fortbildungen (Caelo Campus Continuing Education) Free, accredited continuing education platform for pharmacy staff (pharmacists, PTAs), offering webinars and in-person seminars covering compounding (Rezeptur) topics, analytical methods, and regulatory updates; webinars last 60-90 minutes and award accreditation points.
  • Rezeptursymposium Annual continuing education symposium for pharmacists and pharmacy technicians organized jointly with WEPA Apothekenbedarf, featuring plenary lectures and hands-on workshops; awards 8 accreditation points.
  • Rezepturtage In-person practical training events at Caelo's Hilden facility covering compounding and analytics, with hands-on workshops on topics such as suspensions, plausibility checks, identity testing, and ApBetrO updates.
  • Analysenzertifikate (Analysis Certificates) Service Batch-specific analysis certificates for all Caelo products, accessible via the Dr. Lennartz Laboratory Program with PZN and batch number lookup, and via 2D barcode scanning; certificates are automatically archived in the pharmacy's test protocol.
  • Caelo Rezepturhotline (Compounding Hotline) Telephone hotline providing pharmacy staff with guidance on concrete questions about individual compounding preparations; available Monday-Friday, 09:00-12:00 and 16:00-18:00.
  • Cannabidiol DAC, API DAC-compliant synthetic Cannabidiol in API quality, added to Caelo's API assortment for pharmacy compounding.

Quantifiable outcome

  • 167 tonnes CO2 savings per year through photovoltaic installation
  • +1 more outcomes

Companies that use Caelo

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Caelo technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Caelo partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • WEPA ApothekenbedarfcoreStrategic or Co-development Partner · 7 November 2026Strategic partnership for co-hosting the annual Rezeptursymposium educational event. The 6th edition is scheduled for November 7, 2026 in Leipzig under the motto 'Efficient and safe in compounding daily work'. WEPA and Caelo collaborate on program development, workshops, and participant engagement for pharmacy professionals.
  • DAC/NRF (Deutscher Arzneimittelcodex/Nationales Formularium)coreStrategic or Co-development PartnerReference standards organization whose formulations and guidelines Caelo follows for product development. DAC/NRF experts serve as speakers at Caelo educational events including Rezeptursymposium and Rezepturtage.
  • Dr. Lennartz LaborprogrammcoreTechnology or IntegrationPartnership for integrated certificate management system. Caelo supported development of new certificate server within the Dr. Lennartz laboratory program, enabling automated retrieval and comparison of batch-specific analysis certificates. Caelo is gradually equipping products with 2D codes for scanner integration.
  • pharma4uminorImplementation/ SI/ Consulting PartnerTraining and education provider contributing workshops to the Rezeptursymposium event program.
  • AVOXAminorStrategic or Co-development PartnerPartnership for cosmetic DIY workshop 'Rezeptur Kosmetik - DIY-Kosmetikprodukte in Apothekenqualität selber herstellen' offered at inspirationLab during trade shows.
  • Healthy EntrepreneursminorStrategic or Co-development PartnerSocial enterprise initiative in Eastern Africa (Kenya, Uganda); Caelo supports healthcare access through CSR engagement and quarterly reports shared on website.

Scale indicators8 records

Recent moves8 records

Expansion highlights5 records

Caelo competitors and assessment

Company assessment

Regional players

  • Inresa Arzneimittel: German pharmaceutical company distributing specialty and compounding-relevant products in Germany. Regional peer operating in the same German pharmacy distribution ecosystem as Caelo.

Others

  • AVOXA Mediengruppe: German pharmaceutical trade media and services provider partnering with Caelo on cosmetic compounding workshops. Ecosystem participant rather than direct competitor, but reflects adjacent professional pharmacy services.

Broad incumbents

  • BASF Pharma Solutions: Global pharmaceutical excipients and API supplier from BASF, offering much broader portfolio of ingredients across pharma, food, and cosmetics. Overlaps with Caelo's industrial customer base but at significantly larger scale.
  • Merck KGaA (Life Science / Sigma-Aldrich): Major global supplier of pharmaceutical and laboratory chemicals, APIs, and excipients. Competes in adjacent market segments serving industrial pharma customers, but not specialized in pharmacy compounding like Caelo.

Direct peers

  • Medisca: Canadian pharmaceutical compounding supplier with global distribution of APIs, excipients, and bases to compounding pharmacies. Comparable in product mix and customer focus, with international reach that contrasts with Caelo's domestic-only footprint.
  • PCCA (Professional Compounding Centers of America): US-based supplier of APIs, bases, and compounding support services to independent compounding pharmacies. Comparable business model focused on pharmacy compounding with strong educational/training programs analogous to Caelo Campus.
  • Fagron: Belgian-based global leader in pharmaceutical compounding supplies, offering APIs, excipients, and semi-solid bases to pharmacies worldwide. Most direct international peer to Caelo with overlapping product portfolio and customer base.
  • Spectrum Pharmacy Products: US division of Spectrum Chemical supplying compounding pharmacies with APIs and excipients. Comparable in regulatory-grade raw materials distribution to pharmacy compounders.
  • Gallipot: US-based compounding supplies company providing APIs, bases, and equipment to compounding pharmacies. Closely analogous product portfolio targeting pharmacy compounders.
  • LETCO Medical: US-based distributor of compounding chemicals, equipment, and supplies serving compounding pharmacies. Direct competitor in the raw materials-for-compounding niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Caelo social profiles

Digital presence

Caelo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Caelo leadership team

Management profile

Number of profiles

Profiles3 records

Caelo funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Caelo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Caelo

What does Caelo do?

Caelo (Caesar & Loretz GmbH) manufactures and distributes high-quality pharmaceutical raw materials and finished compounding products for German community and hospital pharmacies, the pharmaceutical/food/cosmetics industries, and selected end consumers. Its portfolio spans active pharmaceutical ingredients (APIs), compounding substances, semi-solid bases, medicinal herbs, essential oils, OTC products, and finished medicinal products such as Dronabinol concentrate, complemented by toll manufacturing and pharmacist training services.

Is Caelo a public or private company?

Caelo is a private company. It is classified as family owned and is currently operating.

When was Caelo founded?

Caelo was founded in 1893. It employs 251 to 500 people.

Where is Caelo based?

Caelo is headquartered in Hilden, Germany, in the Europe region.

How does Caelo make money?

Four revenue lines are on record. Pharmaceutical Raw Materials (API, Rezeptursubstanzen) is the primary driver. The others are finished Products (HV-Produkte, Standardzulassungen), toll Manufacturing (Lohnherstellung) and training and Education (Caelo Campus).

Who are Caelo's main competitors?

Inresa Arzneimittel is listed as a regional player. AVOXA Mediengruppe is listed as an others. Broad incumbents are BASF Pharma Solutions and Merck KGaA (Life Science / Sigma-Aldrich). Direct peers are Medisca, PCCA (Professional Compounding Centers of America), Fagron, Spectrum Pharmacy Products, Gallipot and LETCO Medical.

Does Caelo have an API?

No public API is recorded for Caelo.

What industry is Caelo in?

Caelo's product category is Pharmaceutical Raw Materials. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply), with a secondary code of CRADAOAF, Preservatives & Antimicrobials (Sorbates, Benzoates, Natamycin, Cultured Dextrose). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The future of tradingMedios Completes Caelo AcquisitionMedios completed its acquisition of Caelo, strengthening its European compounding essentials business. Ulrich von der Linde stepped down from Caelo management upon closing. The deal is expected to support Medios' growth in the compounding segment.The future of tradingMedios completes 74% acquisition of Caelo after antitrust clearanceMedios completed its acquisition of a 74% stake in Caelo on Oct. 1, 2026, after antitrust clearance. The deal positions Medios as Germany's market leader in active pharmaceutical ingredients for pharmacies and hospitals. Caelo is expected to generate about EUR 40 million in revenue this year.FinanzNachrichten.deLaufende Fusionskontrollverfahren: Medios AG, Berlin; Erwerb einer Mehrheitsbeteiligung an und alleiniger Kontrolle über die Caesar und Loretz GmbH, Hilden ('Caelo') von der C&L-Gruppe, HildenThe Bundeskartellamt has opened a merger control procedure (file B3-96/26) concerning the acquisition by the C&L-Gruppe of a majority stake and sole control of the Caesar and Loretz GmbH ('Caelo') in Hilden. The transaction involves markets including ointment filling and packaging, OTC drug manufacturing, contract manufacturing, medicinal cannabis, dronabinol and active pharmaceutical ingredients. No filing date, value or conditions were disclosed.Investing.comMedios H1 2026 slides: revenue tops €1bn amid margin pressure By Investing.comMedios AG reported first-half 2026 revenue of €1,075 million, marking its first time surpassing €1 billion in a half-year period, but faced margin compression with EBITDA pre declining 5.1% to €44.0 million. The company simultaneously announced the acquisition of a 74% stake in Caesar & Loretz GmbH (Caelo) for €9.4 million to expand its presence in the German active pharmaceutical ingredient market. Management revised full-year guidance to raise revenue expectations while lowering profitability targets due to persistent price pressures and regulatory headwinds.Investing.comEarnings call transcript: Medios lifts H1 2026 revenue above €1 billion By Investing.comMedios AG reported a revenue increase of 8.4% to €1.075 billion for the first half of 2026, marking the first time the company has surpassed €1 billion in half-year sales. Despite this growth, EBITDA pre fell by 5.1%, prompting a reduction in the company's full-year earnings guidance. The company is focusing on improvements in operational efficiency amidst challenging pricing pressures and recently announced the acquisition of Caelo, which is expected to strengthen its compounding business in Germany.FinanzNachrichten.deMedios übernimmt Mehrheit an CaeloMedios has acquired a 74% stake in Caesar & Loretz GmbH (Caelo), with the completion of the deal pending regulatory approval. Caelo employs around 240 staff at Hilden and Bonn and anticipates significant revenue for the current fiscal year.FinanzNachrichten.deEQS-Adhoc: Medios AG - Erwerb einer Mehrheitsbeteiligung an der Caesar & Loretz GmbH (Caelo) und Eintritt in den deutschen Markt für pharmazeutische Wirk- und HilfsstoffeMedios AG has signed a contract to acquire a 74% majority stake in Caesar & Loretz GmbH (Caelo), a leading provider of pharmaceutical active ingredients, excipients, and raw materials for pharmacies, clinics, and industrial customers in Germany. Caelo expects revenues of approximately €40 million for the current fiscal year, while the credit-financed purchase price is in the upper single-digit million range and dependent on the company's future performance. The transaction marks Medios' entry into the German market for pharmaceutical ingredients and establishes the foundation for a European platform for Compounding Essentials, with closing expected in Q4 2026.